2023 Q4 Form 10-Q Financial Statement

#000149315223037830 Filed on October 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $3.301K
YoY Change 10.77%
Cost Of Revenue $0.00 $27.53K
YoY Change 0.56%
Gross Profit $0.00 -$24.23K
YoY Change -0.68%
Gross Profit Margin -734.11%
Selling, General & Admin $14.56M $5.502M $1.080M
YoY Change 590.04% 409.4% 52.68%
% of Gross Profit
Research & Development $4.920M $5.941M
YoY Change
% of Gross Profit
Depreciation & Amortization $42.88K $22.01K $1.086K
YoY Change 328.8% 1926.52% -75.97%
% of Gross Profit
Operating Expenses $17.14M $11.44M $1.248M
YoY Change 620.26% 817.1% 76.39%
Operating Profit -$17.14M -$11.44M -$1.272M
YoY Change 620.26% 799.63% 73.82%
Interest Expense $155.0K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$46.10K $295.7K -$1.917K
YoY Change -71.19% -15526.76%
Pretax Income -$17.03M -$11.74M -$1.270M
YoY Change 570.6% 824.27% 54.77%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$17.02M -$11.28M -$1.028M
YoY Change 673.7% 997.02% 66.07%
Net Earnings / Revenue -31147.89%
Basic Earnings Per Share -$1.09
Diluted Earnings Per Share -$1.23 -$1.09 -$0.23
COMMON SHARES
Basic Shares Outstanding 10.73M shares 10.66M shares 3.499B shares
Diluted Shares Outstanding 10.36M shares 4.580M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.55M $22.86M $420.0K
YoY Change 10453.55% 5342.23% 2216.6%
Cash & Equivalents $29.55M $22.86M $418.3K
Short-Term Investments
Other Short-Term Assets $113.9K $68.75K $30.00K
YoY Change 127.82% 129.17% 67.69%
Inventory
Prepaid Expenses
Receivables $247.00
Other Receivables $50.82K $2.360K $20.00K
Total Short-Term Assets $29.71M $22.93M $461.6K
YoY Change 8502.62% 4867.56% 615.71%
LONG-TERM ASSETS
Property, Plant & Equipment $6.408M $285.5K $117.5K
YoY Change 2845.41% 142.89% 82.73%
Goodwill
YoY Change
Intangibles $7.116M $5.912M $4.829M
YoY Change 43.14% 22.41%
Long-Term Investments $0.00 $150.0K
YoY Change -100.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $13.97M $6.197M $5.097M
YoY Change 161.63% 21.59% 228.72%
TOTAL ASSETS
Total Short-Term Assets $29.71M $22.93M $461.6K
Total Long-Term Assets $13.97M $6.197M $5.097M
Total Assets $43.68M $29.13M $5.558M
YoY Change 668.49% 423.99% 244.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.954M $2.164M $440.0K
YoY Change 376.62% 391.79% 51.72%
Accrued Expenses $115.0K $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $67.02K
YoY Change
Total Short-Term Liabilities $5.670M $2.648M $2.937M
YoY Change 102.64% -9.86% 172.24%
LONG-TERM LIABILITIES
Long-Term Debt $9.704M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $58.58K $56.63K $25.21K
YoY Change -25.82% 124.62% -78.14%
Total Long-Term Liabilities $58.58K $56.63K $25.21K
YoY Change -25.82% 124.62% -78.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.670M $2.648M $2.937M
Total Long-Term Liabilities $58.58K $56.63K $25.21K
Total Liabilities $34.37M $22.70M $2.962M
YoY Change 1094.62% 666.4% 8.96%
SHAREHOLDERS EQUITY
Retained Earnings -$101.7M -$83.96M -$57.39M
YoY Change 70.62% 46.3%
Common Stock $12.76K $10.69K $3.655M
YoY Change 149.74% -99.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.891M $6.546M $1.193M
YoY Change
Total Liabilities & Shareholders Equity $43.68M $29.13M $5.558M
YoY Change 668.49% 423.99% 244.17%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$17.02M -$11.28M -$1.028M
YoY Change 673.7% 997.02% 66.07%
Depreciation, Depletion And Amortization $42.88K $22.01K $1.086K
YoY Change 328.8% 1926.52% -75.97%
Cash From Operating Activities -$8.344M -$8.465M $1.070M
YoY Change 583.96% -891.12% -197.02%
INVESTING ACTIVITIES
Capital Expenditures $5.560M -$1.158M $2.320M
YoY Change 1885.89% -149.91% 238.38%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.560M $1.158M -$2.320M
YoY Change 1885.89% -149.91% -438.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.39M 10.14M 1.280M
YoY Change 1456.65% 692.39% 251.91%
NET CHANGE
Cash From Operating Activities -8.344M -8.465M 1.070M
Cash From Investing Activities -5.560M 1.158M -2.320M
Cash From Financing Activities 20.39M 10.14M 1.280M
Net Change In Cash 6.487M 2.836M 30.00K
YoY Change -3514.4% 9351.77% -156.03%
FREE CASH FLOW
Cash From Operating Activities -$8.344M -$8.465M $1.070M
Capital Expenditures $5.560M -$1.158M $2.320M
Free Cash Flow -$13.90M -$7.307M -$1.250M
YoY Change 826.99% 484.56% -30.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001540684
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2022Q4 ATLX Deferred Consideration From Royalties Sold
DeferredConsiderationFromRoyaltiesSold
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
us-gaap Gross Profit
GrossProfit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
ATLX Issuance Of Common Stock In Connection With Purchase Of Mining Rights
IssuanceOfCommonStockInConnectionWithPurchaseOfMiningRights
usd
us-gaap Other Noncash Expense
OtherNoncashExpense
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
ATLX Increase Decrease In Deferred Consideration From Royalties Sold
IncreaseDecreaseInDeferredConsiderationFromRoyaltiesSold
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41552
dei Entity Registrant Name
EntityRegistrantName
ATLAS LITHIUM CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-2078861
dei Entity Address Address Line1
EntityAddressAddressLine1
Rua Buenos Aires
dei Entity Address Address Line2
EntityAddressAddressLine2
10 – 14th floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Belo Horizonte
dei Entity Address Country
EntityAddressCountry
BR
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30.315-570
dei City Area Code
CityAreaCode
+55
dei Local Phone Number
LocalPhoneNumber
31-3956-1109
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
ATLX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10729260 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22857357 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
280525 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2355 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
17705 usd
CY2023Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
68746 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
47093 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
22928458 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
345414 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285475 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217550 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5911516 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4971267 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
150000 usd
CY2023Q3 us-gaap Assets
Assets
29125449 usd
CY2022Q4 us-gaap Assets
Assets
5684231 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2647549 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2776474 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2647549 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2797967 usd
CY2023Q3 ATLX Deferred Consideration From Royalties Sold
DeferredConsiderationFromRoyaltiesSold
20000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56630 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78964 usd
CY2023Q3 us-gaap Liabilities
Liabilities
22704179 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2876931 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10688727 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10688727 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5110014 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5110014 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10689 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5111 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91608657 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62258116 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1115798 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-981040 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83958011 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59585949 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
6545538 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1696453 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
-124268 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1110847 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6421270 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2807300 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29125449 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5684231 usd
CY2022Q3 us-gaap Revenues
Revenues
3301 usd
us-gaap Revenues
Revenues
6145 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
27534 usd
us-gaap Cost Of Revenue
CostOfRevenue
63732 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-24233 usd
us-gaap Gross Profit
GrossProfit
-57587 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
212579 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
45978 usd
us-gaap Professional Fees
ProfessionalFees
403179 usd
us-gaap Professional Fees
ProfessionalFees
189999 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1058808 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
478899 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3672552 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1101290 usd
CY2023Q3 us-gaap Officers Compensation
OfficersCompensation
530538 usd
CY2022Q3 us-gaap Officers Compensation
OfficersCompensation
172730 usd
us-gaap Officers Compensation
OfficersCompensation
2055875 usd
us-gaap Officers Compensation
OfficersCompensation
559319 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3699588 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
386287 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7680742 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1029476 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
5941109 usd
CY2022Q3 us-gaap Exploration Expense
ExplorationExpense
163800 usd
us-gaap Exploration Expense
ExplorationExpense
11633434 usd
us-gaap Exploration Expense
ExplorationExpense
184221 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11442622 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1247694 usd
us-gaap Operating Expenses
OperatingExpenses
25445782 usd
us-gaap Operating Expenses
OperatingExpenses
3064305 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11442622 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1271927 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25445782 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3121892 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
295731 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1917 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
154820 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3883 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
295731 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1917 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
154820 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3883 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11738353 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1270010 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25600602 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3118009 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-11738353 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-1270010 usd
us-gaap Profit Loss
ProfitLoss
-25600602 usd
us-gaap Profit Loss
ProfitLoss
-3118009 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-458878 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-241818 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1228540 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-687311 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11279475 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1028192 usd
us-gaap Net Income Loss
NetIncomeLoss
-24372062 usd
us-gaap Net Income Loss
NetIncomeLoss
-2430698 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10363991 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10363991 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4579688 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4579688 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8818972 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8818972 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4579688 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4579688 shares
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-11738353 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-1270010 usd
us-gaap Profit Loss
ProfitLoss
-25600602 usd
us-gaap Profit Loss
ProfitLoss
-3118009 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-247224 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-267594 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-141333 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
38870 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-11985577 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1537604 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-25741935 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3079139 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-466622 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-472483 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1235115 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-673300 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11518955 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1065121 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24506820 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2405839 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
456866 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2613736 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1029476 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38870 usd
ATLX Issuance Of Jupiter Gold Common Stock In Connection With Sales Made Under Private Offerings
IssuanceOfJupiterGoldCommonStockInConnectionWithSalesMadeUnderPrivateOfferings
50000 usd
ATLX Issuance Of Sale Of Apollo Resources Common Stock In Connection With Equity Offerings
IssuanceOfSaleOfApolloResourcesCommonStockInConnectionWithEquityOfferings
525000 usd
us-gaap Profit Loss
ProfitLoss
-3118009 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2595939 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2807300 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20525116 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
750000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2017923 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2639 usd
ATLX Exercise Of Warrants
ExerciseOfWarrants
360482 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5399745 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-141333 usd
ATLX Issuance Of Jupiter Gold Common Stock In Connection With Sales Made Under Private Offerings
IssuanceOfJupiterGoldCommonStockInConnectionWithSalesMadeUnderPrivateOfferings
300000 usd
us-gaap Profit Loss
ProfitLoss
-25600602 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6421270 usd
us-gaap Profit Loss
ProfitLoss
-25600602 usd
us-gaap Profit Loss
ProfitLoss
-3118009 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7680742 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1029476 usd
ATLX Issuance Of Common Stock In Connection With Purchase Of Mining Rights
IssuanceOfCommonStockInConnectionWithPurchaseOfMiningRights
750000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
30116 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
-16717 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
159991 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1154 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5450 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
579 usd
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-21653 usd
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-8722 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
333269 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1938819 usd
ATLX Increase Decrease In Deferred Consideration From Royalties Sold
IncreaseDecreaseInDeferredConsiderationFromRoyaltiesSold
20000000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-22334 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-83715 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3314979 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-258293 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
98041 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
46990 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1423936 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2526836 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1521977 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2573826 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
20522531 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2613736 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
300000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
575000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20822531 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3188736 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-38701 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38870 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22576832 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
395487 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280525 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22776 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22857357 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
418263 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zyk5s8idCjZe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i><span style="text-decoration: underline"><span id="xdx_86A_zdbtgo1jLzSk">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
757323 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
471848 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285475 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
659282 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
441732 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217550 usd
CY2023Q3 us-gaap Depreciation
Depreciation
22008 usd
us-gaap Depreciation
Depreciation
30116 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1086 usd
us-gaap Depreciation
Depreciation
16717 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5911516 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4971267 usd
CY2023Q1 us-gaap Area Of Land
AreaOfLand
45.77
CY2023Q3 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
2163863 usd
CY2022Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
408874 usd
CY2023Q3 ATLX Mineral Rights Payable Current And Noncurrent
MineralRightsPayableCurrentAndNoncurrent
483687 usd
CY2022Q4 ATLX Mineral Rights Payable Current And Noncurrent
MineralRightsPayableCurrentAndNoncurrent
2367600 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2647549 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2776474 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56630 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78964 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of our issued and outstanding shares of common stock at a ratio of 1-for-750 (the “Reverse Stock Split”). Following the Reverse Stock Split, each 750 shares of our issued and outstanding shares of common stock were automatically converted into one issued and outstanding share of common stock, without any change in par value per share.
CY2023Q1 us-gaap Area Of Land
AreaOfLand
45.77
ATLX Stock Options Conceded In Cashless Exercises
StockOptionsConcededInCashlessExercises
542 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
15458 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
174697 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.1063
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
58685 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2156793 usd
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
385626 shares
ATLX Grant Date Fair Value Of Vesting
GrantDateFairValueOfVesting
6922121 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
181364 shares
us-gaap Payments For Rent
PaymentsForRent
4598 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p id="xdx_807_eus-gaap--LossContingencyDisclosures_zlQ488O97Pm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black; background-color: white"><b>NOTE 8 – <span id="xdx_825_zbHprczqekze">RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black; background-color: white"><i><span style="text-decoration: underline">Currency Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black; background-color: white">We operate primarily in Brazil which exposes us to currency risks. Our business activities may generate intercompany receivables or payables that are in a currency other than the functional currency of the entity. Changes in exchange rates from the time the activity occurs to the time payments are made may result in it receiving either more or less in local currency than the local currency equivalent at the time of the original activity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black; background-color: white">Our consolidated financial statements are denominated in U.S. dollars. Accordingly, changes in exchange rates between the applicable foreign currency and the U.S. dollar affect the translation of each foreign subsidiary’s financial results into U.S. dollars for purposes of reporting in the consolidated financial statements. Our foreign subsidiaries translate their financial results from the local currency into U.S. dollars in the following manner: (a) income statement accounts are translated at average exchange rates for the period; (b) balance sheet asset and liability accounts are translated at end of period exchange rates; and (c) equity accounts are translated at historical exchange rates. Translation in this manner affects the shareholders’ equity account referred to as the foreign currency translation adjustment account. This account exists only in the foreign subsidiaries’ U.S. dollar balance sheets and is necessary to keep the foreign subsidiaries’ balance sheets in agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>

Files In Submission

Name View Source Status
atlx-20230930_cal.xml Edgar Link unprocessable
0001493152-23-037830-index-headers.html Edgar Link pending
0001493152-23-037830-index.html Edgar Link pending
0001493152-23-037830.txt Edgar Link pending
0001493152-23-037830-xbrl.zip Edgar Link pending
atlx-20230930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
atlx-20230930_def.xml Edgar Link unprocessable
atlx-20230930_pre.xml Edgar Link unprocessable
atlx-20230930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending